Form D · Pharmaceuticals
Romark Laboratories, L.C.
Tampa, FL · CIK 0001470263
Offering snapshot reported Feb 11, 2016 · SEC filing
- Reported sold
- Yet to sell Offering amount: $40M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 19, 2014 | Amendment | $10,750,100 | $8,835,250vs Jun 24, 2014 | 112 | SEC filing |
| Jun 24, 2014 | Initial | $1,914,850 | No comparison | 19 | SEC filing |
| Jun 13, 2014 | Amendment | $14,999,520 | $14,849,520vs May 16, 2013 | 107 | SEC filing |
| May 16, 2013 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Nov 18, 2011 | Amendment | $9,647,700 | $9,558,800vs Dec 21, 2010 | 126 | SEC filing |
| Jan 4, 2011 | Amendment | $23,111,817 | $8,044,201vs Jan 26, 2010 | 155 | SEC filing |
| Dec 21, 2010 | Initial | $88,900 | No comparison | 2 | SEC filing |
| Jan 26, 2010 | Amendment | $15,067,616 | $14,767,616vs Aug 28, 2009 | 97 | SEC filing |
| Aug 28, 2009 | Initial | $300,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.4M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-257323
6% of the gross proceeds raised and a Warrant to purchase Common Units equal to 15% of the number of Common Units into which the Notes are convertible.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| International Assets Advisory, LLC | 10645 |
Source: Form D, filed Feb 11, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marc S. Ayers | Director, Executive |
| Jeff Crowther | Director, Executive |
| Kurt Frahn | Executive |
| W. Seymour Holt | Director |
| Emmet B. Keefe | Executive |
| Emmet B. Keeffe | Executive |
| W. Andrew Krusen, Jr. | Director |
| Celine E. Rossignol | Executive |
| Jean Francois Rossignol | Director, Executive |
| Brian Schnieders | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3000 Bayport Drive Suite 200
Tampa, FL, 33607
Tampa, FL, 33607